Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test

• Published in: Clinical and experimental rheumatology 2020-01, Vol.38 Suppl 125 (3), p.59-64
• Main Authors: Schmalzing, Marc, Nau, Lena F, Gernert, Michael, Froehlich, Matthias, Schwaneck, Eva C, Pecher, Ann-Christin, Saur, Sebastian, Tony, Hans-Peter, Henes, Melanie, Henes, Joerg
• Format: Article
• Language: English
• ISSN: 0392-856X

To assess and compare sexual dysfunction (SDF) in female patients with systemic sclerosis (SSc) or systemic lupus erythematosus (SLE), to correlate sexual function with disease characteristics and depression, and to evaluate a short questionnaire (Qualisex) as a screening test. Female patients with systemic sclerosis or systemic lupus erythematosus in two German tertiary university hospitals were evaluated in a prospective study. A self-designed questionnaire, the Female Sexual Function Index (FSFI), the Qualisex, and the Beck's depression inventory were used. 171 female patients were included into the study (83 with SSc, and 88 with SLE). 62.6% (52 of 83) of SSc patients and 67.0% (59 of 88) of SLE patients were sexually active. Only 9.6% of SSc patients and 14.8% of SLE patients had ever discussed sexual problems with their physician. Significantly more SSc patients would wish to discuss sexuality with their physician more intensively (37.3% vs. 28.4% in SLE patients, p=0.011). Among the 51 sexually active and evaluable SSc patients a mean FSFI of 25.53 (±5.06) was found, with a FSFI value defining sexual dysfunction (SDF) (